ENTA - Enanta Pharmaceuticals Inc. (ENTA) CEO Dr. Jay Luly on Q1 2020 Results - Earnings Call Transcript
Enanta Pharmaceuticals, Inc. (ENTA)
Q1 2020 Results Conference Call
February 06, 2020 04:30 PM ET
Company Participants
Carol Miceli - Director, IR
Dr. Jay Luly - President and CEO
Paul Mellett - CFO
Nathalie Adda - SVP and CMO
Conference Call Participants
Brian Abrahams - RBC
Eric Joseph - JP Morgan
Akash Tewari - Wolfe Research
Liisa Bayko - JMP Securities
Brian Skorney - Baird
Iris Long - Berenberg Capital Management
Presentation
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Enanta Pharmaceuticals First Quarter Financial Results Conference Call. At this